Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori Eradication for Metachronous Gastric Cancer Prevention
NCT02407119Phase 3Active, not recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jun 2003
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clarithromycin, amoxicillin in Helicobacter pylori infection, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Jun 2003; status: active, not recruiting.
02
Drugs
clarithromycinamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02407119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02407119.